Tamiflu on Track to Be an Over-The-Counter Drug
![capsule](https://staging.thevaccinereaction.org/wp-content/uploads/2020/01/Oseltamivir-1024x576.jpg)
In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC) rights for Tamiflu (oseltamivir), an antiviral drug licensed for the treatment of influenza infections. Genentech, a member of the Roche Group, currently sells Tamiflu in the United States only for prescription use.1 Tamiflu is a […]